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Canine distemper virus (CDV) was shown to use dog nectin-4 as a receptor to gain entry into epithelial
cells. RNA from dog placenta or MDCK kidney cells was isolated and cDNAs were prepared. Two splice
variants of dog nectin-4 were identiﬁed. A deletion of 25 amino acids was found in the cytoplasmic
domain of dog nectin-4 from MDCK cells, corresponding to a splice variant that is also seen in murine
nectin-4, and did not affect its role as a receptor. Both dog nectin-4 and human nectin-4 could function
as an entry factor for CDV containing an EGFP reporter gene. Inhibition of dog nectin-4 expression by
RNAi or nectin-4 antibodies decreased CDV titers and EGFP ﬂuorescence. Finally, dog nectin-4 also
promotes syncytia formation, which could be inhibited by siRNA treatment. These data conﬁrm that
dog nectin-4 can be used by CDV to gain entry into epithelial cells, and facilitate virus spread.
& 2012 Elsevier Inc. All rights reserved.Introduction
The family Paramyxoviridae, within the order Mononegavirales,
consists of four genera, Morbillivirus, Paramyxovirus, Rubulavirus
and Pneumovirus. Morbilliviruses are highly contagious pathogens
that are responsible for some of the most devastating diseases
that affect mammals worldwide. Members of this genus include
measles virus (MeV), canine distemper virus (CDV), peste des
petits ruminants virus (PPRV), rinderpest virus (RPV), phocine
distemper virus (PDV) and dolphin morbillivirus (DMV) (Diallo,
1990; Rima and Duprex, 2006).
Canine distemper virus (CDV) produces a contagious disease
that elicits high mortality in a wide range of terrestrial carnivores
(Appel, 1970; Barrett, 1999; Deem et al., 2000; Harder and
Osterhaus, 1997; Martella et al., 2008). CDV is closely related to
MeV in terms of gene organization and genome sequences
(Harder and Osterhaus 1997; Barrett 1999). Like MeV, CDV is a
negative strand RNA virus whose RNA genome is associated with
nucleocapsid protein (NP), phosphoprotein (P), and an RNA
polymerase (L). Surrounding the nucleocapsid is a membranell rights reserved.
crobiology & Immunology,
ilding 7th Floor, Room 7C,
ardson).
.envelope that contains 2 glycoproteins, the hemagglutinin (H),
used for attachment to the host cell receptor, and the fusion (F)
protein, required for entry and syncytia formation. A matrix
protein (M) lies on the inner side of the viral envelope and helps
maintain the integrity of the virus. Both MeV and CDV produce
similar symptoms and have comparable incubation periods in
their respective natural hosts. However, CDV has a broader host
range than MeV, and can infect dogs, coyotes, wolves, cats, lions,
tigers, minks, ferrets, raccoons, pandas, bears, and civets (Martella
et al., 2008). CDV exhibits a higher frequency of neurological
involvement than MeV, which can vary with different strains of
the virus (Beineke et al., 2009). Ferrets are particularly susceptible
to neurotropic strains of CDV and have proven to be an excellent
small laboratory animal model for studying the spread of virus
from the lymphatic system, to epithelial cells, and subsequently
the central nervous system (Ludlow et al., 2012; Sawatsky et al.,
2012; von Messling et al., 2003) The virus enters the canine host
by the nasal or oral route and initiates replication in lymphoid
tissues. In dogs, the incubation period may range from 1 to
4 weeks. Transient fever peaks 3 to 6 days after infection as the
virus spreads throughout the lymphatic system. At 6 to 9 days
post-infection, CDV spreads to epithelial cells in most organs.
Respiratory, intestinal, and dermatologic symptoms are evident
10 days post-infection. The infected animal exhibits loss of
appetite, ocular and nasal discharge, and tonsillitis. Like MeV,
CDV infection is associated with transient immunosuppression
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Krakowka et al., 1980; von Messling et al., 2004). If the host
immune response is weak, the virus replicates extensively in the
epithelial cells and subsequently the central nervous system.
Demyelinating encephalitis can occur when the virus persists
and establishes chronic infections in the brain (Beineke et al.,
2009). These can produce neurological symptoms between 20 and
50 days post-infection. In the pre-vaccine era, canine distemper
disease was endemic in domestic dogs (Martella et al., 2008,
2007). From the 1960s onward, attenuated canine distemper virus
vaccines contributed to a decrease in the percentage of CDV-
infected domestic dogs in countries with high vaccine coverage,
leaving wild carnivores as the main reservoir (Croghan, 1966;
Keeble, 1962; Rockborn, 1959).
Both CDV and MeV enter susceptible cells using surface
protein receptors. Three cellular receptors have been identiﬁed
to date. The signaling lymphocyte activation molecule (SLAM),
which is expressed on the surfaces of activated T- and B-lympho-
cytes, macrophages, and dendritic cells (Wang et al., 2004), serves
as an immune cell receptor for morbilliviruses (Baron, 2005; Hsu
et al., 2001; Seki et al., 2003; Tatsuo et al., 2000, 2001). CD46, an
inhibitor of complement activation, acts as a cellular receptor for
vaccine and laboratory adapted strains of measles viruses (Dorig
et al., 1993; Naniche et al., 1993). Recently, nectin-4 (poliovirus-
receptor-like-4, PVRL4) has been identiﬁed as an epithelial cell
receptor for MeV and CDV (Muhlebach et al., 2011; Noyce et al.,
2011; Noyce and Richardson, 2012; Pratakpiriya et al., 2012). The
V domain of nectin-4 was shown to bind strongly to MeV
hemaglutinin (H) protein (Muhlebach et al., 2011). A recombinant
CDV, containing mutations in the H protein that make it blind to
the epithelial receptor, infects the lymphatic system to produce
immunosuppression, but cannot spread to epithelial cells to
produce clinical disease and virus shedding (Sawatsky et al.,
2012). Nectin-4 was also recently suggested to be an epithelial
and neurotropic receptor for CDV but the sequence of dog nectin-
4 and a comprehensive characterization of this receptor was not
reported (Pratakpiriya et al., 2012).
The nectin family belongs to the immunoglobulin (Ig) super-
family comprised of at least ﬁve members, including nectins 1–4
and the prototypic poliovirus receptor (PVR) (Takai et al., 2008).
They consist of three Ig-like ectodomains (V, and two C2
domains), in addition to a transmembrane region, and a cyto-
plasmic tail. V domains are involved in homotypic or heterotypic
interactions between the nectins, whereas C2 domains enhance
the afﬁnity of these interactions (Fabre et al., 2002; Satoh-
Horikawa et al., 2000; Takai et al., 2008). Nectins are normally
localized to the adherens junctions, where they deﬁne cell-to-cell
interactions and boundaries (Kurita et al., 2011; Takai et al.,
2008). Interestingly nectin-4 expression is up regulated on the
surface of many different types of cancer cells and has been
suggested to be a tumor cell marker for lung, ovarian and
metastatic breast cancers (Derycke et al., 2010; Fabre-Lafay
et al., 2005; Fabre-Lafay et al., 2007; Takano et al., 2009). This
observation could support the use of MeV as an oncolytic agent
for treating a variety of cancers (McDonald et al., 2006; Russell
and Peng, 2009).
In this study we conﬁrmed that CDV uses dog nectin-4 as a
receptor to gain entry into host cells. Two variants of dog nectin-4
were identiﬁed from either dog placenta or MDCK tissue culture
cells. The major difference between these two proteins was the
deletion of 25 amino acids in the cytoplasmic domain of one of
the variants. However, this deletion did not yield any difference in
the ability of CDV to infect cells expressing these dog nectin-4
proteins. Overexpression of dog nectin-4 in Vero monkey kidney
cells resulted in localization of the protein to the cell surface,
similar to what was observed previously with human nectin-4.Both dog nectin-4 and human nectin-4 could function as an entry
factor for CDV that contained an enhanced green ﬂuorescent
protein (EGFP) reporter gene. Inhibition of dog nectin-4 expres-
sion by RNAi, or blocking virus–receptor interaction with poly-
clonal antibodies directed against nectin-4, resulted in decreased
CDV titers and EGFP ﬂuorescence. Finally, dog nectin-4 also
promotes efﬁcient viral spread and syncytia formation, which
could also be inhibited by siRNA treatment. Taken together, these
data conﬁrm that dog nectin-4 can be used by CDV to gain entry
into epithelial cells, and spread from cell to cell.Results
Wild-type CDV strain 5804PeH infects cells expressing human or dog
nectin-4
CDV and MeV are both members of the Morbillivirus genus in
the family Paramyxoviridae. Previous ﬁndings have shown that
members of this genus share common tropism and pathologies,
including the use of SLAM as a cell receptor on cells of the
immune system (Baron, 2005; Hsu et al., 2001; Seki et al., 2003;
Tatsuo et al., 2000). We ﬁrst investigated whether wild-type CDV
strain 5804PeH could use human nectin-4 as a receptor to gain
entry and mount a productive infection in these cells. Vero cells
overexpressing human nectin-4 were very susceptible to CDV
5804PeH, producing large GFP positive syncytia compared to
control Vero cells (Fig. 1). The human breast cancer cell line,
MDA-MB-231, previously shown to be negative for nectin-4
expression and MeV susceptibility (Noyce et al., 2011), was only
susceptible to CDV 5804PeH infection if human nectin-4 was
expressed in these cells (Fig. 1; compare MDA-MB-231 and MDA-
MB-231.hPVRL4). The human nectin-4 positive breast cancer cell
line MCF-7 was also susceptible to wild-type CDV infection,
suggesting that wild-type CDV 5804PeH is able to use the human
nectin-4 receptor to gain entry into cells.
We next wanted to conﬁrm that CDV 5804PeH could infect a
more relevant dog epithelial cell line, MDCK. We obtained a
number of MDCK cell lines and determined whether they were
susceptible to wild-type CDV infection (Fig. 1; MDCK-super tubes,
MDCK-super domes, and MDCK). We observed that only MDCK
variants expressing dog Nectin-4 were susceptible to CDV infec-
tion. Interestingly, MDCK-super domes had a lower level of
nectin-4 surface expression and a small number of syncytia
following infection with CDV 5804 compared to MDCK cells,
suggesting that the abundance of nectin-4 on the cell surface
dictates its infectivity by wild type strains of CDV. The MDCK-
super tube cell line did not express nectin-4 and was not
susceptible to infection by CDV. Overall, these data suggest that
wild-type CDV can use both human and dog homologues of
nectin-4 to gain entry into cells in vitro.
Molecular cloning of the cDNA for dog nectin-4
We investigated whether wild type strains of CDV could use the
dog homologue of nectin-4 as a cellular receptor. To this end, we
isolated two putative clones of dog nectin-4 from either Labrador
retriever (LR) placenta or MDCK tissue culture cells (Fig. 2A). These
two clones differed in that the MDCK nectin-4 clone had a 25
amino acid deletion in the endodomain (aa 412–436) as a result of
alternative splicing (Fig. 2B). This splice variant aligned seamlessly
with the mouse variant 2 at this region. Thus, similar to murine
nectin-4, the dog nectin-4 gene encodes at least two splice variants
that can both act as receptors for wild-type CDV. Interestingly, the
dog nectin-4 sequences obtained were different from the dog
nectin-4 sequence predicted from the female boxer dog genome
Fig. 1. Wild-type CDV 5804PeH can use either human or dog nectin-4 to gain entry into cells. Cells of monkey (Vero or Vero.hPVRL4; MOI 0.5), human (MDA-MB-231,
MDA-MB-231.hPVRL4, MCF-7; MOI 5.0), and dog (MDCK-super tubes, MDCK-super domes, MDCK; MOI 5.0) origin were used to infect with CDV 5804PeH at the indicated
MOI. Fluorescence images were captured four days post infection and overlaid with phase contrast images. The inset histograms depict the cell surface expression proﬁle of
nectin-4 in the corresponding cell line (isotype ctrl antibody, IgG – shaded; nectin-4 antibody, nectin-4 – red). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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sequence was truncated by the insertion of a stop codon at amino
acid 438. This may be another variant but could also be the result
of a genome sequencing error. Overall, the full-length LR and
shorter MDCK nectin-4 sequences were 94.3% and 89.9% identical
at the amino acid level to human nectin-4, respectively. Identical
full-length and short nectin-4 sequences were determined from
cDNAs prepared from the placenta of a papillon dog (NCBI
Genbank KC165685 and KC165686). The V domain of nectin-4
has been implicated in receptor binding (Muhlebach et al., 2011),
and the dog homologue contains only 3 changes in this region,
A31P, P92A, and N106S, compared to its human counterpart
(Fig. 2A).
Cell lines transduced with retroviruses containing the dog nectin-4
gene express the receptor on their cell surface
Although the dog nectin-4 cDNA clones were highly similar to
human nectin-4 at the amino acid level, we wanted to conﬁrm
that these glycoproteins localized to the cell surface. The expres-
sion pattern of these cDNAs in Vero cells was analyzed by
immunoﬂuorescence microscopy (Fig. 3). To generate cell surface
expression of these molecules, we constructed retrovirus expres-
sion vectors expressing the membrane-bound form of human
(Vero.hNectin-4), MDCK (Vero.MDCKNectin-4), and Labrador
retriever nectin-4 (Vero.LRNectin-4). Vero cells were transduced
with VSV-G pseudotyped retrovirus particles created in the
Phoenix amphotropic cell system (Swift et al., 2001). Stable celllines expressing the nectin-4 proteins were selected in the
presence of G418, followed by immunoﬂuorescence staining and
confocal microscopy (Fig. 3A) or ﬂow cytometry (Fig. 3B). Both the
MDCK nectin-4 and LR nectin-4 proteins were localized to the
plasma membrane according to confocal microscopy analysis, as
was human nectin-4. Flow cytometry conﬁrmed that the majority
of cells in the stable population expressed nectin-4. Human
nectin-4, MDCK nectin-4, and LR nectin-4 cell lines exhibited
increased ﬂuorescent signals for nectin-4 compared to the
Vero.Neo negative control cells.
CDV replicates efﬁciently in cells that express dog nectin-4
To determine whether dog nectin-4 could be used as a receptor for
the CDV wild-type strain 5804PeH, the Vero stable cell lines expres-
sing MDCK or LR nectin-4 were infected at an MOI of 0.5 and syncytia
formation and virus titers were monitored over a 3d time course
(Fig. 4). Both clones of dog nectin-4 induced formation of syncytia of
comparable sizes following infection with CDV at 3d post-infection
(Fig. 4A). Interestingly, syncytia formation in the nectin-4-expressing
cells seemed to be larger compared to those in the VerodogSLAMtag
cells. Vero.Neo control cells exhibited a low background infection
with CDV 5804PeH, as evidenced by isolated single ﬂuorescent cells
which did not produce syncytia. Similar observations were previously
made with MeV infections of Vero cells (Hashimoto et al., 2002). By
day 3-post infection, CDV 5804PeH virus titers were higher in the
Vero cells expressing dog SLAM, MDCK nectin-4, or LR nectin-4, as
compared to the Vero.Neo control cells (Fig. 4B). The CDV 5804PeH
Fig. 2. Amino acid sequences of human, mouse and dog (MDCK cell and Labrador retriever) nectin-4. (A) The amino acid sequences of human, mouse variant 1 (var 1) and
variant 2 (var 2), Labrador retriever (LR), and MDCK nectin-4 are aligned. Residues having similarity are shaded (dark shading represents identical residues; light shading
represents conservative changes). (B) Schematic diagrams of the two dog nectin-4 clones from Labrador retriever placenta (LR Nectin-4) or MDCK cell culture cells (MDCK
Nectin-4) compared to the predicted dog nectin-4 (Pred. Dog nectin-4). The Ig V and C2 domains, along with the transmembrane domain (TM) are indicated.
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4 and Vero.LRNectin-4 cell lines (Fig. 4B). hNectin-4 also appeared to
function equally well as a receptor for CDV (Fig. 1).
The afﬁnity of MeV H protein for Nectin-4 receptor was
previously reported to be 4–5 times greater than for SLAM/
CD150 (Muhlebach et al., 2011). This could potentially result in
increased efﬁciency of infection by CDV or measles virus when
using nectin-4 as a receptor. This did not appear to be the case
with CDV 5804PeH virus above, nor was it true when a stable
Vero cell line expressing human nectin-4 (hNectin-4) was
infected with wtMeV (IC323-EGFP) at an MOI of 0.05 (Fig. 5).
Signiﬁcant syncytia formation in both the hSLAM and hNectin-4
cell lines was observed by 32 h post infection (Fig. 5A). Just aswas the case with CDV, MeV replicated to similar levels in
hNectin-4 expressing cells compared to those observed in
hSLAM-expressing cells (Fig. 5B). Collectively, these data suggest
that wild-type CDV 5804PeH and IC323 wtMV-EGFP can use
nectin-4 and SLAM equally well as cellular receptors for virus
entry and pathogenesis.
Diminished dog nectin-4 expression or inhibition by polyclonal
antibodies yields inefﬁcient CDV infection
To conﬁrm that dog nectin-4 was a bona ﬁde receptor for wild-
type strains of CDV, siRNA or antibody inhibition assays were
utilized in attempts to block the initial stage of virus attachment
Fig. 3. Dog nectin-4 is localized to the cell surface. (A) Vero stable cell lines
expressing human (Vero.hNectin-4), MDCK (Vero.MDCKNectin-4), or LR (Vero.LR-
Nectin-4) nectin-4 were grown on glass coverslips, ﬁxed in paraformaldehyde, and
stained with a goat anti-human nectin-4 polyclonal antibody (red). Nuclei were
visualized with TO-PRO-3 nuclear stain (grey). Three hundred nanometer image
z-stacks were captured on a Zeiss upright confocal microscope and analyzed using
ZEN 2011 image capture software (Zeiss). Scale bar¼10 mm. (B) Flow cytometry
analysis reveals dog nectin-4 is expressed on the cell surface of Vero MDCK nectin-
4 and LR nectin-4 cells. Vero stable cell lines were incubated with phycoerythrin
(PE)-conjugated mouse monoclonal antibody speciﬁc for human nectin-4, or a
PE-conjugated mouse IgG2a control antibody (shaded histogram). The Y-axis
represents cell counts and the X-axis represents ﬂuorescence intensity. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
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knock down exogenous levels of MDCK nectin-4 in the Vero stable
cell line. A scrambled control, individual MDCK nectin-4 siRNAs
(siRNA 1 or siRNA 5), or a pool of 4 siRNAs that were speciﬁc for
either MDCK nectin-4 (siRNA pool) were transfected into
Vero.MDCKNectin-4 cells for 72 h. Analysis by ﬂow cytometry
demonstrated that dog nectin-4 surface expression was reduced
by 75–80 % in the MDCK nectin-4 siRNA-treated samples, com-
pared to control siRNA-treated cells (Fig. 6A, lower panel). The
cells were subsequently infected with CDV 5804PeH, after which
syncytia formation and virus titers were monitored 3d post
infection (Fig. 6B and C). The number and size of syncytia weredramatically decreased in the MDCK nectin-4 siRNA treated cells
(Fig. 6B) compared to the control siRNA and mock treated
samples. CDV titers decreased approximately 2-logs in the MDCK
nectin-4 siRNA treated cells, indicating that CDV uses dog nectin-
4 to infect these cells. Interestingly, RNAi treatment with siRNA 1
was just as effective at inhibiting the surface expression of nectin-
4 and preventing the infection by CDV as the siRNA pool.
These data were conﬁrmed using nectin-4 polyclonal antibo-
dies to block the attachment of CDV to the dog nectin-4 receptor.
A rabbit polyclonal antibody directed against human nectin-4 was
used to inhibit binding of CDV to cells expressing MDCK nectin-4.
Vero.MDCKNectin-4 cells were pre-treated with varying concen-
trations of human nectin-4 antibodies, followed by infection with
CDV 5804PeH at an MOI of 0.5. After the inoculation period, cells
were washed rigorously to remove any unbound virus, and
subsequently incubated with media. Incubation with polyclonal
antibodies directed against human nectin-4 effectively blocked
the number and size of syncytia, compared to the IgG control-
treated cells (Fig. 6D). We also observed an approximate 2-log
decrease in the titer of CDV produced from cells treated with
nectin-4 antibodies, compared to the IgG controls (Fig. 6E). Taken
together, the siRNA and nectin-4 antibody inhibition studies
strongly indicate that wild-type strains of CDV can use dog
nectin-4 as a cellular entry receptor.
Efﬁcient CDV cell to cell spread requires dog nectin-4
We next investigated whether nectin-4 was also involved in
cell to cell spread of CDV in cultured cells. VerodogSLAMtag cells
were infected with wild-type CDV for 90 min at an MOI of 4,
trypsinized and mixed with uninfected Vero.MDCKNectin-4 cells
that had been treated with control or MDCK nectin-4 siRNA (ratio
1:5, infected:uninfected siRNA treated cells). Following attach-
ment of the cells to the culture plate, they were overlaid with
medium containing methylcellulose, and syncytia were counted
3d later. We observed a marked reduction in the number and size
of infected foci in the Vero.MDCKNectin-4 cells that had been
treated with MDCK nectin-4 siRNA, compared to mock or control
siRNA-treated cells (Fig. 7, compare panel A and B with panel C).
Overall, these data suggest that nectin-4 is responsible for both
initial virus entry, and cell-to-cell spread between cells expres-
sing dog nectin-4.Discussion
Our laboratory and another have previously demonstrated that
MeV attachment and entry into primary human epithelial cells
and adenocarcinoma cell lines require the epithelial cell receptor,
nectin-4 (Muhlebach et al., 2011; Noyce et al., 2011; Noyce and
Richardson, 2012). In the current study we show that dog nectin-
4 serves as an epithelial receptor for CDV, another related
member of the Morbillivirus subgroup of family Paramyxoviridae.
Wild-type CDV 5804PeH could use both human and dog nectin-4
as a receptor on cells. Speciﬁc knockdown of dog nectin-4 reduced
its overall surface expression, resulting in a signiﬁcant decrease in
CDV infectivity in Vero.MDCKNectin-4 and Vero.LRNectin-4 cells.
Consistent with this ﬁnding, neutralizing antibodies directed
against nectin-4 could also inhibit CDV infection of these cells.
Finally, dog nectin-4 expression was found to contribute to
efﬁcient cell-to-cell spread of CDV.
During morbillivirus infections, aerosols containing the viruses
enter the upper respiratory tract and target dendritic cells and
macrophages via DC-SIGN or SLAM receptors (de Witte et al.,
2008; Ferreira et al., 2010; Lemon et al., 2010; Muhlebach et al.,
2011; Noyce et al., 2011; Noyce and Richardson, 2012). These
Fig. 4. Wild-type CDV 5804PeH efﬁciently infects dog nectin-4 expressing Vero cells. Vero stable cell lines expressing dog SLAM (Vero.dogSLAMtag), MDCK nectin-4,
(Vero.MDCK Nectin-4), LR nectin-4 (Vero.LR Nectin-4), or a control plasmid (Neo) were infected at an MOI of 0.5 with CDV 5804PeH. (A) Phase contrast and ﬂuorescence
images were captured and overlaid to visualize the extent of virus replication (GFP) and syncytia formation over 3d. (B) Dog nectin-4 results in a signiﬁcant increase in CDV
5804PeH virus titers compared to Vero cells alone. CDV-infected cells were harvested at various times post infection and titered on VerodogSLAMtag cells. Data are the
means from three independent experiments, and error bars represent the SEM.
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viruses like MeV and CDV can infect a population of uninfected T
and B cells expressing SLAM. Infected lymphocytes disseminate
the virus throughout the host via the peripheral blood and
lymphatic systems (Iwatsuki et al., 1995; Krakowka et al., 1980;
Lemon et al., 2010; Sawatsky et al., 2012; von Messling et al.,
2003, 2004). The virus disseminates to primary and secondary
lymphoid organs as well as lymph nodes in the gastro-intestinal
tract (Appel, 1970; Blixenkrone-Moller, 1989; Iwatsuki et al.,
1995; von Messling et al., 2004). Finally, CDV enters the epithelial
cells of the respiratory, gastro-intestinal, urinary, and endocrine
systems via the epithelial receptor (Appel, 1970; Frisk et al., 1999;
Ludlow et al., 2012; von Messling et al., 2004). This receptor
functions as an exit receptor, promoting ampliﬁcation and sub-
sequent release of the virus from airway, urinary, and gastro-
intestinal epithelial cells. All body secretions contain the
virus and are very contagious. Recombinant CDV, containing a
mutated H protein that could not recognize the epithelial recep-
tor, infected immune cells and caused immunosuppression(Sawatsky et al., 2012). This mutated virus could not produce
clinical signs of infection, spread to the central nervous system,
nor was it shed from the infected host. Neurovirulent strains of
CDV can subsequently infect cells of the central nervous system
using receptors, which still remain uncharacterized (Ludlow et al.,
2012).
MDCK cells are an epithelial cell line derived from the kidney
of an adult female cocker spaniel. Over the years, numerous
strains have been derived from the heterogeneous population of
cells in the parental cell line, MDCK (NBL-2) (Dukes et al., 2011).
These include the MDCK super tube and super dome cells used in
Fig. 1. Parental MDCK cells have previously been used to isolate
and propagate clinically relevant CDV strains (Dietzel et al., 2011;
Lednicky et al., 2004; Mochizuki, 2006; Pillet and von Messling,
2009; Tan et al., 2011). In addition, MDCK cells failed to support
the replication of CDV that contained H mutations making it blind
to the epithelial cell receptor (Sawatsky et al., 2012). MDCK (NBL-2)
cells can be infected with either wild type MeV or wild type CDV,
and FACS analysis showed that these cells express nectin-4 on their
Fig. 5. MeV (IC323-GFP) replication of human nectin-4 expressing Vero stable
cells. (A) Vero stable cell lines expressing human SLAM (Vero.hSLAM) or nectin-4
(Vero.hNectin-4) were infected at an MOI of 0.05 with wtMeV (IC323-GFP). Phase
contrast and ﬂuorescence images were captured and overlaid to visualize the
extent of virus replication (GFP) and syncytia formation 32 h post infection.
(B) Human nectin-4 expression results in an increase in wtMeV (IC323-GFP)
compared to Vero cells alone (Neo). MeV-infected cells were harvested at 32 h
post infection and titered on Vero-hSLAM cells. Data are means from three
independent experiments, and error bars represent the SEM.
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cloned and sequenced the nectin-4 epithelial receptor from these
cells and provided evidence that dog nectin-4 can function as an
epithelial cell receptor for CDV. Another variant of dog nectin-4 was
identiﬁed from the placenta of a Labrador retriever, where it is
highly expressed, which corresponds to the full-length protein that
was previously reported (Reymond et al., 2001). These two clones
differed in that the MDCK nectin-4 clone had a 25 amino acid
deletion in the cytoplasmic endodomain (aa 412–436) as a result of
alternative splicing (Fig. 2B). In addition, both splice variants were
also isolated from the placenta of a papillon dog (GenBank
KC165685 and KC165686), raising the possibility that at least two
protein variants may be present within tissues that actively express
dog nectin-4. The smaller dog nectin-4 variant aligned seamlessly
with mouse variant 2 at this region. Both dog nectin-4 proteins can
act equally well as receptors for wild-type CDV. Infections of
Vero.MDCKNectin-4 and Vero.LRNectin-4 cell lines were more
extensive than those in MDCK cells, due to their increased levels
of nectin-4 expression. The titers of CDV produced from these cell
lines were also much higher. Reduction of endogenous levels of dog
nectin-4 with RNAi and inhibition of receptor–virus interactions
with antibodies were less effective at preventing CDV infection in
MDCK cells (data not shown). This is because MDCK cells are not as
susceptible to CDV infection and serial passage of virus-infectedcells is often required to increase the percentage of infected cells
(Dietzel et al., 2011; Pillet and von Messling, 2009; Sawatsky et al.,
2012). Second, MDCK cells exhibited very high doubling times,
making the use of inhibitory antibodies and RNAi approaches less
effective at preventing CDV infection. Consequently, Vero.MDCK-
Nectin-4 and Vero.LRNectin-4 cells were chosen for the RNAi and
nectin-4 antibody inhibition studies.
There is little species variation in nectin-4 sequences between
human, mouse, and dogs ((Noyce et al., 2011); Fig. 2). Mouse nectin-4
can function as a receptor for MeV (Noyce et al., 2011) and human
nectin-4 functions as a receptor for CDV (Fig. 1). Nectin-4 is an exit
receptor that operates in the later stages of infection when virus is
ampliﬁed and released from epithelial cells. Host tropism appears to
be established during the initial stages of infection through use of the
lymphocyte receptor SLAM. Mouse SLAM/CD150 cannot function as a
receptor for either MeV or CDV, and attachment appears to be
dictated by the amino acid sequence in the V loop of this protein
(Hsu et al., 2001; Tatsuo et al., 2001). The V loop of nectin-4 is also
involved in virus attachment but there are only 3 amino acids that
differ in the V domain of the dog homologue, and 6 different amino
acids in the V domain of mouse, when compared to the human
protein sequence. Therefore, it may be possible to follow the release
of MeV and CDV particles in a human/dog SLAM transgenic mouse
having a background where interferon production or function is
limited (Ferreira et al., 2010; Ohno et al., 2007; Welstead et al., 2005).
Overexpression of dog nectin-4 in interferon-deﬁcient Vero
cells facilitates CDV entry, productive infection, and syncytium
formation. However, we also observed low levels of CDV produc-
tion without syncytia formation in Vero cells lacking dog nectin-4.
This was previously observed with MeV infections of Vero cells
(Hashimoto et al., 2002). These single-infected cells have been
reported in MeV-infected CHO, COS-1, and Vero cells at a
frequency of 2–3 logs below that of SLAM-infected. RNAi treat-
ment or polyclonal antibodies directed against PVRL4 did not
affect these single cell background infections. Vero cells have
depressed innate immunity (Chew et al., 2009; Mosca and Pitha,
1986) and CDV has also been reported to attach to the low afﬁnity
heparan sulfate receptor in a non-speciﬁc manner (Fujita et al.,
2007). We postulate that the virus can enter the cell by an F
protein-independent mechanism such as macropinocytosis. This
route of entry may or may not be relevant during in vivo infections
but probably accounts for the high background of CDV production
in cells lacking known receptors.
Our data demonstrated that dog nectin-4 facilitates CDV entry
and cell-to-cell spread in cultured Vero cells that express this
receptor. Using a binding assay based upon virus-speciﬁc anti-
bodies and FACS analysis, we previously showed that nectin-4/
PVRL4 was a bona ﬁde receptor used during attachment of
MeV to the host cell (Noyce et al., 2011). This is undoubtedly
the case for CDV. Pratakpiriya et al. recently reported that dog
nectin-4 is an epithelial receptor for CDV, although the origin and
sequence of dog nectin-4 was not mentioned (Pratakpiriya et al.,
2012). RNAi was not used to verify receptor usage by knocking
down nectin-4 expression. We also showed that dog nectin-4
functioned equally well or better than dogSLAM as a receptor and
proved that it was involved in syncytia formation and cell-to-cell
spread of CDV. The other group also suggested that nectin-4
functioned as a receptor in the brain using immunoﬂuorescence
microscopy, but this must be substantiated further. Further
studies using primary epithelial cells from CDV susceptible
species must also be performed to show how infected immune
cells or virus access the nectin-4 receptor, which is normally
localized to the adherens junctions between cells. As was pre-
viously done with MeV, we are testing the susceptibility of dog
adenocarcinomas to CDV as a possible prelude to oncolytic
therapy against various cancers.
Fig. 6. Wild-type CDV 5804PeH requires dog nectin-4 to efﬁciently infect cells. Vero.MDCKNectin-4 cells were transfected with a scrambled oligonucleotide control (ctrl
siRNA), a pool of siRNAs speciﬁc for MDCK nectin-4 (siRNA pool), or individual siRNAs speciﬁc for MDCK nectin-4 (siRNA #1 or siRNA #5). (A) Nectin-4 surface expression
was detected with a PE-conjugated nectin-4 antibody following gene knockdown with control siRNA (red line) or MDCK nectin-4 siRNA (blue line) (upper panel).
A graphical representation of the relative surface expression of MDCK Nectin-4 following siRNA treatment in three independent experiments is shown in the bottom panel.
Data are presented as means7SEM. (B) Nectin-4 RNAi results in a decrease in CDV infection and syncytia formation compared to Mock or control siRNA treatment.
(C) Titration of CDV 72 h post infection in siRNA-treated Vero.MDCK nectin-4 expressing cells. At three days post infection, cells were harvested and virus titrations were
performed on VerodogSLAMtag cells. Data are presented as means7SEM from three independent experiments. Statistically signiﬁcant differences (ANOVA, Po0.05) are
indicated by astericks. (D) Human nectin-4 antibodies inhibit wild-type CDV infection in Vero cells expressing MDCK nectin-4. Vero.MDCKNectin-4 cells were grown on
glass coverslips and incubated with varying concentrations of goat IgG or goat anti-human nectin-4 for 30 min prior to, and during a 1 h adsorption of wild-type
CD5804PeH. Virus infection and syncytia formation following CDV infection was monitored by ﬂuorescence microscopy 3 days post infection. (E) Virus-infected
Vero.MDCKNectin-4 cells treated with polyclonal antibodies were harvested 3 days post infection and titered on VerodogSLAMtag cells. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Cell culture and virus infections
Vero cells, MDCK-super tubes (ATCC CRL-2285) and MDCK-
super domes (ATCC CRL 2286) were purchased from the American
Type Culture Collection (Manassas, VA). MDCK (ATCC CCL-34)
cells and Phoenix cells were obtained from Dr. Craig McCormick
and MDA-MB-231 and MCF-7 human breast cancer cell lines
were generously provided by Dr. David Hoskin (Dalhousie,
University). The recombinant Ichinoise-B 323 (IC323) wild type
measles virus (MeV) isolate expressing the enhanced green
ﬂuorescent protein (eGFP) reporter gene (IC323-EGFP wtMeV)was obtained from Dr. Roberto Cattaneo (Mayo Clinic, Rochester).
The recombinant wild-type CDV 5804PeH strain expressing eGFP
(von Messling et al., 2004) was provided by Dr. Veronika von
Messling (Duke-NUS, Singapore). Wild type MeV and CDV
were propagated in Vero human SLAM and VerodogSLAMtag
cells, respectively.
Molecular cloning of dog nectin-4 cDNA and V domain mutant
Total RNA was extracted from either Labrador retriever (LR)
placenta (generously provided by Mr. Don Bates of Doindogs
kennel, Dartmouth, NS), papillon placenta (Ms. Stephanie
Callahan-Corkum and Ms. Mary Taplin of Country Critter Sitters,
Fig. 7. Dog nectin-4 is required for cell to cell spread of wild-type CDV 5804PeH.
Vero.MDCKNectin-4 cells were treated with scrambled oligonucleotides (ctrl
siRNA) or a pool of MDCK nectin-4 siRNAs. After 72 h these cells were mixed
with VerodogSLAMtag cells previously infected with CDV 5804PeH at an MOI of
4 for 90 min (ratio 5:1, VeroMDCK nectin-4:infected VerodogSLAMtag cells). The
cells were subsequently overlaid with methylcellulose, and infectious foci were
visualized by ﬂuorescence microscopy 3 days following cell mixing.
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transcribed with SuperScript III (Life Technologies) using a ran-
dom hexamer primer. To amplify the cDNA encoding dog nectin-
4, we performed PCR using consensus primers derived from the 50
and 30 regions of human, bovine, and mouse nectin-4; sense (50-
CCAATGCCTCTATCCCTGGGAGCCGAG-30) and antisense (50-
GGAGGCAGGCCTGGGTCAGACCAGGTG-30). Nested PCR was sub-
sequently performed using sense and antisense primers contain-
ing NheI and EcoRI restriction sites, respectively, at the
50 ends. The puriﬁed PCR product from either LR placenta or
MDCK cDNA was ligated into pcDNA 3.1 () (Life Technologies)
and subsequently sequenced. Pairwise protein alignments were
performed using Geneious (Drumond et al., 2010) sequence
alignment software. The individual immunoglobulin-like domains
of nectin-4 were mapped using the ScanProsite tool (de Castro
et al., 2006).
Creation of stable cell lines by retrovirus transduction
To create stable cell lines expressing dog nectin-4 from either
LR placenta or MDCK cells, dog nectin-4 was sub cloned into the
pBMN-IRES-Neo retrovirus (a kind gift from C. McCormick
(Dalhousie University) using the BamHI and EcoRI restriction
sites. Human nectin-4 was subcloned into the pBMN-IRES-Neo
retrovirus using the BamHI and EcoRI restriction sites. Phoenix
cells were subsequently transfected using Lipofectamine 2000
and supernatant containing MDCK nectin-4- or LR nectin-4-
expressing viruses were collected at 3d post transfection. Super-
natants were brieﬂy clariﬁed at 1000 g for 5 min and subse-
quently incubated with Vero or MDA-MB-231 cells in the
presence of 12 mg/ml polybrene for ninety minutes at 1000 g.
Forty-eight hours post retrovirus transduction, the Cells weresub-cultured in the presence of either 1000 mg/ml G418 for 14
days or until no cells were present on the control cell plate. These
cells were tested for nectin-4 expression by ﬂow cytometry and
indirect immunoﬂuorescence microscopy before being used for
virus infections.
Virus infections
MDA-MB-231, MCF-7, and MDCK cell lines were seeded into
12-well plates so they were semi-conﬂuent approximately 24 h
later. Cells were infected with 5804PeH wtCDV at an MOI of
5.0 TCID50/cell for 1 h at 37 1C. Cell monolayers were washed
twice with PBS and incubated with DMEM containing 5% FCS.
Images of infected monolayers were captured 4 days post infec-
tion and overlaid with phase micrographs.
Vero cells stably expressing empty vector (Vero.Neo), human
nectin-4 (Vero.hNectin-4), MDCK nectin-4 (Vero.MDCKNectin-4),
or Labrador retriever placental nectin-4 (Vero.LRNectin-4) were
seeded into 12-well plates so they were conﬂuent approximately
24 h later. Vero cells stably expressing human (Vero.hSLAM) or
dog (Vero.dogSLAMtag) SLAM were used as positive controls for
wtMeV or wtCDV infection and replication, respectively. Cells
were infected with either IC323 EGFP wtMeV or 5804PeH wtCDV
at an MOI of 0.05 or 0.5 TCID50/cell, respectively, for 1 h at 37 1C.
Cell monolayers were washed twice with PBS and replaced with
DMEM containing 5% FCS. Cells were harvested at day 1, 2, and
3 for wtCDV infections and at 32 h for wtMeV infections. TCID50
titers were determined by 50% end-point titration on Vero.dog-
SLAMtag or Vero.hSLAM cells for wtCDV and wtMeV, respectively,
according to the Spearman-Ka¨rber method. Data were expressed
as means7the standard error of the mean.
Virus spread assay
To assess the impact of nectin-4 on spread of CDV to non-
infected cells expressing dog nectin-4, Vero.dogSLAMtag cells
were infected at an MOI of 4. After 90 min, the virus inoculum
was removed and cells were washed, trypsinized, and mixed at a
1:5 ratio with Vero.MDCKNectin-4 cells that had previously been
transfected for 72 h with 50 pmol of control siRNA or a pool siRNA
speciﬁc to knockdown MDCK nectin-4 mRNA. Three hours after
seeding, the medium was removed and cells were overlaid with
DMEM supplemented with 5% FCS and 1.5% methylcellulose
(Sigma). Infectious foci were imaged 72 h after mixing.
Flow cytometry
To determine the cell surface expression of dog nectin-4 on
Vero stable cell lines, cells were analyzed by ﬂow cytometry.
Brieﬂy, cells were washed with PBS, non-enzymatically disso-
ciated and subsequently blocked in 2.5 mg of normal human IgG
(R&D Systems) for 10 min on ice followed by the addition of 10 ml
of either PE-conjugated human nectin-4 (R&D Systems FAB2659P)
or PE-conjugated mouse IgG2B isotype control (R&D Systems
IC0041P) antibodies for 45 min on ice. Cells were washed twice
in PBS containing 1% BSA, 5 mM EDTA, and 0.1% sodium azide and
then ﬁxed in 1% paraformaldehyde. Samples were run on a Cyan
ADP Flow Cytometer (Beckman Coulter) and data were processed
using FlowJo cytometry analysis software (Tree Star, Inc).
Confocal microscopy
Vero nectin-4 stable cell lines grown on coverslips were ﬁxed
in 4% paraformaldehyde (10 min) and blocked with 5% FCS in PBS
for 1 h at room temperature. Nectin-4 was detected by incubating
the cells with goat anti-human nectin-4 (R&D Systems AF2659) at
R.S. Noyce et al. / Virology 436 (2013) 210–220 2195 mg/ml in PBS containing 5% FCS for 45 min at room temperature.
Cells were subsequently stained with ﬂuorophore-conjugated
secondary antibodies for 30 min at room temperature. Nuclear
DNA was stained (20 min) with TO-PRO-3 stain (Life Technolo-
gies) in PBS containing 0.1% Triton X-100. Cells were mounted
with ﬂuorescent mounting medium and images were acquired
with ZEN 2008 imaging software on a Zeiss LSM 510 upright laser
scanning confocal microscope. Z-sections were captured with a
63 Plan APOCHROMAT (1.4NA) objective lens at 0.3 mm incre-
ments and processed using ZEN 2011 lite and Adobe Photoshop
CS3 using only linear adjustments.
siRNA inhibition of MDCK nectin-4
siRNA speciﬁc to MDCK nectin-4 and negative-control oligonu-
cleotides (D-001810-10–05) were designed and synthesized by
Dharmacon (Lafayette, CO). A pool of four oligonucleotide
sequences targeting MDCK nectin-4 were used: MDCK nectin-4
siRNA #1 (sense, 50-GGG CAG AGG ACG AGG AAG AUU-30), MDCK
nectin-4 siRNA #3 (sense, 50-AGC AGA UGA CCC AGA AAU AUU-30),
MDCK nectin-4 siRNA #5 (sense, 50-UCA AAC AGG CCA UGA ACC
AUU-30), and MDCK nectin-4 siRNA #7 (sense, 50-CUC CAG GAC
CAG AGG AUC AUU-30). Brieﬂy, a total of 50 pmol of either the non-
targeting control siRNA, the MDCK nectin-4 pool (12.5 pmol of
each siRNA), or individual MDCK nectin-4 siRNAs (50 pmol of
siRNA ]1 or ]5) were reverse transfected into Vero-MDCK nectin-
4-expressing cells with lipofectamine 2000 (Life Technologies,
Burlington ON) according to the manufacturer’s instructions.
Transfected cells were allowed to grow for an additional 48 h
before being reverse transfected with siRNA duplexes again. Three
days following the initial transfection, cells were infected with
5804 PeH CDV at an MOI of 0.1. Infected cells were viewed by
ﬂuorescence and phase microscopy using a Leica DMI4000B
inverted microscope (Leica Microsystems) 3d post infection and
then harvested to determine virus titers.
Data analysis
Data were expressed as means7the standard error of the
mean unless otherwise indicated. Analysis of variance (ANOVA)
was performed to identify statistically signiﬁcant differences in
CDV 5804PeH titrations following nectin-4 knockdown. P values
below 0.05 were considered statistically signiﬁcant. Overlays of
phase and ﬂuorescence micrographs were processed using only
linear adjustments in Photoshop CS3.
Nucleotide sequence accession numbers
The GenBank accession numbers for Labrador retriever nectin-
4 and MDCK cell nectin-4 cDNA sequences are JX629803 and
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